Search Results - "Agathon, D"

62 PHASE II HCVac STUDY OF TG4040 IMMUNOTHERAPEUTIC IN COMBINATION WITH PEGIFNa2a AND RIBAVIRIN IN GENOTYPE 1 CHC TREATMENT NAÏVE PATIENTS: SVR24 FINAL RESULTS by Wedemeyer, H, Janczewska Kazek, E, Wlodzimierz, M, Stanciu, C, Habersetzer, F, Carreno, V, Di Bisceglie, A, Tanasescu, C, Flisiak, R, Romero-Gomez, M, Fich, A, Hennequi, M, Bain, C, Zerr, P, Agathon, D, Adda, N, Bonnefoy, J.-Y, Inchauspé, G, Ancian, P, Limacher, J.-M

Get full text

1403 SIGNIFICANT IMPROVEMENT OF COMPLETE EVR IN HCVAC PHASE II CLINICAL TRIAL WHEN ADDING TG4040 THERAPEUTIC VACCINE TO PEGIFNα2A AND RIBAVIRIN by Wedemeyer, H, Janczewska, E, Wlodzimierz, M, Stanciu, C, Habersetzer, F, Carreno, V, Di Bisceglie, A.M, Tanasescu, C, Flisiak, R, Romero-Gomez, M, Fich, A, Zemmour, C, Fournillier, A, Zerr, P, Agathon, D, He, H, Bonnefoy, J.-Y, Inchauspe, F, Limacher, J.-M

Get full text

Efficacy of Immunotherapy With TG4040, Peg-Interferon, and Ribavirin in a Phase 2 Study of Patients With Chronic HCV Infection by Di Bisceglie, Adrian M, Janczweska–Kazek, Ewa, Habersetzer, François, Mazur, Wlodzimierz, Stanciu, Carol, Carreno, Vicente, Tanasescu, Coman, Flisiak, Robert, Romero–Gomez, Manuel, Fich, Alexander, Bataille, Vincent, Toh, Myew–Ling, Hennequi, Marie, Zerr, Patricia, Honnet, Géraldine, Inchauspé, Geneviève, Agathon, Delphine, Limacher, Jean–Marc, Wedemeyer, Heiner

“…Background & Aims TG4040 is a modified vaccinia Ankara (MVA) virus that expresses the hepatitis C virus (HCV) proteins NS3, NS4, and NS5B. We performed a phase…”
Get full text

Excavation of a fossilized biliary stent: demonstration of extraction methods for migrated biliary stent by Nguyen, Andrew K., MD, MBA, Girgis, Agathon, MD, Lim, Brian S., MD, MCR

Get full text